Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
celecoxib (DRGT-46)
i
Other names:
DRGT-46
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Tavanta Therap
Drug class:
COX2 inhibitor
Related drugs:
‹
celecoxib (3)
amlodipine/celecoxib (1)
parecoxib (1)
CA102N (0)
apricoxib (0)
ECP-1014 (0)
celecoxib oral (0)
ETS2101 (0)
VT-11CR (0)
celecoxib (3)
amlodipine/celecoxib (1)
parecoxib (1)
CA102N (0)
apricoxib (0)
ECP-1014 (0)
celecoxib oral (0)
ETS2101 (0)
VT-11CR (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
MSI-H/dMMR
Colorectal Cancer
MSI-H/dMMR
Colorectal Cancer
toripalimab-tpzi + DRGT-46
Sensitive: C3 – Early Trials
toripalimab-tpzi + DRGT-46
Sensitive
:
C3
toripalimab-tpzi + DRGT-46
Sensitive: C3 – Early Trials
toripalimab-tpzi + DRGT-46
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login